These data suggest that intestine-specific deletion of Cyp24a1 can lower PTH and FGF23 levels in a model of CKD without precipitating hypercalcemia or hyperphosphatemia and without altering the severity of kidney disease. The gene discussed is CYP24A1; the disease is hyperphosphatemia.